Pharmaceutical R&D Partnerships
Oncology
Key Facts
About DarwinHealth
DarwinHealth is a privately held, New York-based biotechnology company founded in 2015, operating at the intersection of diagnostics, drug discovery, and precision oncology. Its core intellectual property is a proprietary computational platform, leveraging systems biology and its 'Oncotecture' framework, to elucidate tumor master regulators and actionable checkpoints from patient data, thereby guiding therapeutic matching and novel target identification. The company pursues a dual business model: providing diagnostic services to match patients with therapies and leveraging its platform for internal drug discovery and pharmaceutical partnerships. DarwinHealth appears to be in an early commercial or pre-revenue stage, focusing on technology validation and partnership development.
View full company profileTherapeutic Areas
Other Oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| Bi-XDC with PROTACs | Coherent Biopharma | IND-enabling |
| Bi-XDC with RPT | Coherent Biopharma | Early-stage |
| mRNA Anticancer Vaccine | Sunshine Biopharma | Preclinical Research |
| Biosimilar Bevacizumab | Organon (2) | Phase 3 |
| Biosimilar Pembrolizumab | Organon (2) | Phase 3 |
| BCL-2 Inhibitor Program | Vincerx Pharma | Preclinical |
| Not specified in provided content | 3Sbio | Various |
| Preclinical Projects | Zion Pharma | Preclinical |
| Attenukine Oncology Candidate | Teva | Phase 1 |
| XEMA Tumor Marker ELISA Kit | XEMA Group | Commercial |
| KRAS inhibitor | Risen Pharma Tech | Preclinical/Phase 1 |
| KEAP1 Activator Program | Vividion Therapeutics | Phase 1 |